Literature DB >> 18701469

Tumors sound the alarmin(s).

Seth B Coffelt1, Aline B Scandurro.   

Abstract

Recent evidence suggests that inflammatory molecules play critical roles in the development and progression of numerous tumors. However, one specific group of inflammatory molecules whose importance has been established in host immune responses, termed alarmins, has been largely overlooked in cancer biology. The function of several alarmins-including the defensins, LL-37, and HMGB1-in tumor development, progression, or suppression is discussed here. Taken together, these studies indicate that alarmins represent potential new targets for manipulation in a variety of tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18701469      PMCID: PMC2755533          DOI: 10.1158/0008-5472.CAN-08-0044

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  Defensins: antimicrobial peptides of innate immunity.

Authors:  Tomas Ganz
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

2.  Activation of gene expression in human neutrophils by high mobility group box 1 protein.

Authors:  Jong Sung Park; John Arcaroli; Ho-Kee Yum; Huan Yang; Haichao Wang; Kuang-Yao Yang; Kang-Hyeon Choe; Derek Strassheim; Todd M Pitts; Kevin J Tracey; Edward Abraham
Journal:  Am J Physiol Cell Physiol       Date:  2003-04       Impact factor: 4.249

3.  In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes.

Authors:  A Lichtenstein; T Ganz; M E Selsted; R I Lehrer
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

4.  The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium.

Authors:  Johan D Heilborn; Margareta Frohm Nilsson; Gunnar Kratz; Günther Weber; Ole Sørensen; Niels Borregaard; Mona Ståhle-Bäckdahl
Journal:  J Invest Dermatol       Date:  2003-03       Impact factor: 8.551

5.  The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells.

Authors:  Judith von Haussen; Rembert Koczulla; Renat Shaykhiev; Christian Herr; Olaf Pinkenburg; Dietlind Reimer; Rainer Wiewrodt; Stefan Biesterfeld; Achim Aigner; Frank Czubayko; Robert Bals
Journal:  Lung Cancer       Date:  2007-08-31       Impact factor: 5.705

6.  Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.

Authors:  Jose R Conejo-Garcia; Fabian Benencia; Maria-Cecilia Courreges; Eugene Kang; Alisha Mohamed-Hadley; Ronald J Buckanovich; David O Holtz; Ann Jenkins; Hana Na; Lin Zhang; Daniel S Wagner; Dionyssios Katsaros; Richard Caroll; George Coukos
Journal:  Nat Med       Date:  2004-08-29       Impact factor: 53.440

7.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

Authors:  Rembert Koczulla; Georges von Degenfeld; Christian Kupatt; Florian Krötz; Stefan Zahler; Torsten Gloe; Katja Issbrücker; Pia Unterberger; Mohamed Zaiou; Corinna Lebherz; Alexander Karl; Philip Raake; Achim Pfosser; Peter Boekstegers; Ulrich Welsch; Pieter S Hiemstra; Claus Vogelmeier; Richard L Gallo; Matthias Clauss; Robert Bals
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

8.  Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion.

Authors:  Seth B Coffelt; Ruth S Waterman; Luisa Florez; Kerstin Höner zu Bentrup; Kevin J Zwezdaryk; Suzanne L Tomchuck; Heather L LaMarca; Elizabeth S Danka; Cindy A Morris; Aline B Scandurro
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

9.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.

Authors:  Paola Scaffidi; Tom Misteli; Marco E Bianchi
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

10.  LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.

Authors:  Q Chen; A P Schmidt; G M Anderson; J M Wang; J Wooters; J J Oppenheim; O Chertov
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  42 in total

1.  Human β-defensin 3 promotes NF-κB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck.

Authors:  Yvonne K Mburu; Koji Abe; Laura K Ferris; Saumendra N Sarkar; Robert L Ferris
Journal:  Carcinogenesis       Date:  2010-11-11       Impact factor: 4.944

Review 2.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense.

Authors:  Yuping Lai; Richard L Gallo
Journal:  Trends Immunol       Date:  2009-02-13       Impact factor: 16.687

Review 3.  Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Authors:  Geetha Srikrishna; Hudson H Freeze
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

4.  M2 macrophages do not fly into a "RAGE".

Authors:  Armando Rojas; Carolina Añazco; Paulina Araya
Journal:  Inflamm Res       Date:  2016-10-03       Impact factor: 4.575

Review 5.  Alarmins: awaiting a clinical response.

Authors:  James K Chan; Johannes Roth; Joost J Oppenheim; Kevin J Tracey; Thomas Vogl; Marc Feldmann; Nicole Horwood; Jagdeep Nanchahal
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

6.  Surveying proteolytic processes in human cancer microenvironments by microdialysis and activity-based mass spectrometry.

Authors:  Markus Hardt; David K Lam; John C Dolan; Brian L Schmidt
Journal:  Proteomics Clin Appl       Date:  2011-12       Impact factor: 3.494

Review 7.  Skewed Signaling through the Receptor for Advanced Glycation End-Products Alters the Proinflammatory Profile of Tumor-Associated Macrophages.

Authors:  Armando Rojas; Paulina Araya; Jacqueline Romero; Fernando Delgado-López; Ileana Gonzalez; Carolina Añazco; Ramon Perez-Castro
Journal:  Cancer Microenviron       Date:  2018-08-08

8.  The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.

Authors:  Seth B Coffelt; Frank C Marini; Keri Watson; Kevin J Zwezdaryk; Jennifer L Dembinski; Heather L LaMarca; Suzanne L Tomchuck; Kerstin Honer zu Bentrup; Elizabeth S Danka; Sarah L Henkle; Aline B Scandurro
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

9.  The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth.

Authors:  Amanda S Büchau; Shin Morizane; Janet Trowbridge; Jürgen Schauber; Paul Kotol; Jack D Bui; Richard L Gallo
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

10.  Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.

Authors:  Seth B Coffelt; Suzanne L Tomchuck; Kevin J Zwezdaryk; Elizabeth S Danka; Aline B Scandurro
Journal:  Mol Cancer Res       Date:  2009-06-02       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.